Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid
Alzheimer's & Dementia · 2023
DOI: 10.1002/alz.13157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2023. Verfasst von Murat Bilgel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Intramural NIH HHS, Vetenskapsrådet.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Understanding longitudinal plasma biomarker trajectories relative to brain amyloid changes can help devise Alzheimer's progression assessment strategies. METHODS We examined the temporal order of changes in plasma amyloid‐β ratio (), glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), and phosphorylated tau ratios (, ) relative to 11 C‐Pittsburgh compound B (PiB) positron emission tomography (PET) cortical amyloid burden (PiB−/+). Participants ( n = 199) were cognitively normal at index visit with a median 6.1‐year follow‐up. RESULTS PiB groups exhibited different rates of longitudinal change in . Change in brain amyloid correlated with change in GFAP ( r = 0.5, 95% CI = [0.26, 0.68]). The greatest relative decline in (−1%/year) preceded brain amyloid positivity by 41 years (95% CI = [32, 53]). DISCUSSION Plasma may begin declining decades prior to brain amyloid accumulation, whereas p‐tau ratios, GFAP, and NfL increase closer in time. HIGHLIGHTS Plasma declines over time among PiB− but does not change among PiB+. Phosphorylated‐tau to Aβ 42 ratios increase over time among PiB+ but do not change among PiB−. Rate of change in brain amyloid is correlated with change in GFAP and neurofilament light chain. The greatest decline in may precede brain amyloid positivity by decades.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, Maryland, USA.
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
- King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
- NIHR Biomedical Research Centre for Mental Health and Biomedical Research, Unit for Dementia at South London and Maudsley, NHS Foundation, London, UK.
- Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.
ORCID-Profile: Murat Bilgel
Förderung
- NIA NIH HHS
- Intramural NIH HHS
- Vetenskapsrådet
Zitieren
APA
Bilgel, M., An, Y., Walker, K. A., Moghekar, A. R., Ashton, N. J., Kac, P. R., Karikari, T. K., Blennow, K., Zetterberg, H., Jedynak, B. M., Thambisetty, M., Ferrucci, L., & Resnick, S. M. (2023). Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13157
Vancouver
Bilgel M, An Y, Walker KA, Moghekar AR, Ashton NJ, Kac PR, et al. Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid. Alzheimer's & Dementia. 2023. doi:10.1002/alz.13157
BibTeX
@article{Bilgel2023,
author = {Bilgel, Murat and An, Yang and Walker, Keenan A and Moghekar, Abhay R and Ashton, Nicholas J and Kac, Przemysław R and Karikari, Thomas K and Blennow, Kaj and Zetterberg, Henrik and Jedynak, Bruno M and Thambisetty, Madhav and Ferrucci, Luigi and Resnick, Susan M},
title = {Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid},
journal = {Alzheimer's & Dementia},
year = {2023},
doi = {10.1002/alz.13157}
}
EUVIMED